Attenuation of suxamethonium myalgias. Effect of midazolam and vecuronium.
We studied the incidence of fasciculations and postoperative myalgias in 100 female outpatients who had laparoscopy under thiopentone, N2O, isoflurane anaesthesia. Four groups of 20 patients each were pretreated with saline (group 1), tubocurarine 0.05 mg/kg (group 2), vecuronium 0.006 mg/kg (group 3), or midazolam 0.025 mg/kg (group 4), followed by suxamethonium 1.5 mg/kg. Group 5 received only vecuronium 0.1 mg/kg as relaxant (no suxamethonium). Fasciculations were graded, and postoperative myalgias rated on the first and third postoperative days. In groups 1-5 the incidence of fasciculations was 95, 15, 25, 95 and 0%; the incidence of myalgias on the first day after operation was 70, 45, 65, 75 and 60%, and on the third day after operation 20, 5, 20, 20, and 5%, respectively. We conclude that pretreatment with vecuronium, but not midazolam, decreases the incidence of fasciculations after suxamethonium (p less than 0.05) and that in this patient population, postoperative myalgias appear to be unrelated to the use of suxamethonium.
Mingus
M L
ML
Department of Anesthesiology, Mount Sinai School of Medicine, New York, NY 10029-6574.
Herlich
A
A
Eisenkraft
J B
JB
D000328:Adult; D004311:Double-Blind Method; D005207:Fasciculation / Q000139:chemically induced; D005260:Female; D006801:Humans; D008874:Midazolam / Q000627:therapeutic use; D009135:Muscular Diseases / Q000139:chemically induced* / Q000517:prevention & control; D010149:Postoperative Pain / Q000139:chemically induced* / Q000517:prevention & control; D011229:Preanesthetic Medication; D011446:Prospective Studies; D013390:Succinylcholine / Q000009:adverse effects*; D013997:Time Factors; D014673:Vecuronium Bromide / Q000627:therapeutic use
D014673:Vecuronium Bromide; D013390:Succinylcholine; D008874:Midazolam